Senior Principal, EVERSANA MANAGEMENT CONSULTING
Ashley comes to EVERSANA from SmartAnalyst where she was Head of Business Development, Europe. In this role, she led all business development activities across Europe, with a focus on developing disease, asset, and portfolio strategies at the earlier stages of clinical development. Projects included global franchise strategy development for a top-20 pharmaceutical company.
Prior to SmartAnalyst, Ashley was Vice President at PharmaVentures, Ltd., a boutique corporate advisory firm that represents mostly sell-side opportunities for both partnering and divestment to global and regional pharmaceutical organizations. There, she was responsible for leading cross-functional teams to deliver valuations, lead transaction activities, and develop a new strategic consulting vertical.
At the same time, Ashley was the Owner of Ochil Life Sciences, Ltd., a business development and training consultancy to support life science clients.
Earlier in her career, Ashley was Global Business Development Head, Prescient Healthcare Group, Assistant Manager, Business Development, Glenmark Generics UK, Account Manager, Teva UK, and a Senior Medical Representative for various organizations.
Ashley holds an MSc. in pharmaceutical analysis from the University of Strathclyde and a BSc. in neuroscience from the University of Glasgow.